India, Sept. 7 -- HORNBACH Holding AG & Co. KGaA (HBH.DE) reported that preliminary net sales for the second-quarter increased by 7.3% to 1.814 billion euros from last year, driven by robust customer ... Read More
India, Sept. 7 -- Justin Moore recently shared a new song, "Missing You Night," via Blue Highway Records. The song captures that all-too-familiar moment when you think you've finally moved on - until... Read More
India, Sept. 7 -- Cognizant Technology Solutions Corp. (CTSH), announced on Monday that it will expand its commitment to the U.S. workforce by hiring 1,500 college graduates, scaling new AI-era job ca... Read More
India, Sept. 7 -- AVI Ltd (AVI.JO) announced a profit for its full year that Increases, from the same period last year The company's bottom line came in at ZAR2.563 billion, or ZAR7.602 per share. Th... Read More
India, Sept. 7 -- Matinas BioPharma Holdings, Inc. (MTNB), a biopharmaceutical company, announced that it has received a notice from NYSE American indicating that it is not in compliance with continue... Read More
India, Sept. 7 -- Conavi Medical Corp. (YU1.F, CNVIF), a commercial-stage medical device company, announced media and digital marketing agreements with Market One Media Group for C$98,000 and with Win... Read More
India, Sept. 7 -- The following biotech stocks reached a 52-week high on September 4, 2026, as various companies reported financial results and anticipated near-term clinical trial readouts. Pro-Dex ... Read More
India, Sept. 7 -- Aeroporto Guglielmo Marconi di Bologna (ADB.MI) announced earnings for first half that Dropped, from the same period last year The company's earnings totaled EUR10.44 million, or EU... Read More
India, Sept. 7 -- German hard rockers Scorpions, who canceled a four-date run in India earlier this year, have postponed their remaining 2026 live dates, including three shows in Mexico and an eight-d... Read More
India, Sept. 7 -- Roivant (ROIV), a commercial-stage biopharmaceutical company, and its subsidiary, Pulmovant, announced that results from the Phase 2 PHocus study of Mosliciguat in patients with pulm... Read More